<!doctype html>
<html lang="en-gb">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  <title>Hereditary Epidermolysis Bullosa Information</title>
  <link rel="stylesheet" href="css/bootstrap.min.css" />
  <link rel="stylesheet" href="css/styles.css" />
  <style>
    /* Add top margin to move the content down */
    #content {
        margin-top: 100px; /* Adjust this value to control the distance moved downward */
    }
    /* Increase the distance between the button and the footer */
    .btn-primary {
        margin-bottom: 50px; /* Adjust this value to control the distance between the button and the footer */
    }
  </style>
</head>

<body>
<header class="header">
<div id="overview" class="container">
  <nav class="navbar navbar-inverse" role="navigation">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#main-nav">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a href="index.html" class="navbar-brand logo"><b>Rare<i>Insight</i></b></a>
    </div>
    <div id="main-nav" class="collapse navbar-collapse">
      <ul class="nav navbar-nav">
        <li class="active" id="firstLink"><a href="index.html" class="scroll-link">Back to Home</a></li>
      </ul>
    </div>
  </nav>
</div>
</header>
<section id="content">
<div class="container">
  <div class="row">
    <div class="col-md-12">
      <h2 class="text-center"><br/><br/>Hereditary Epidermolysis Bullosa 遺傳性表皮分解性水泡症</h2>
      <br/> <br/>
      <p><strong>Hereditary Epidermolysis Bullosa (遺傳性表皮分解性水泡症) is a rare genetic disorder characterized by the formation of easily ruptured blisters on the skin and mucous membranes. Due to abnormal skin structure, patients with this disease have skin that is very sensitive to minor friction or injury, which can easily cause blisters and ulcers.</strong></p>  
      
      <h3><b>Symptoms</b></h3>
      <p><strong>Symptoms of Hereditary Epidermolysis Bullosa include:</strong></p>
      <ul>
        <li>Skin easily forms blisters</li>
        <li>Ulcers in the mouth and throat</li>
        <li>Formation of skin scars</li>
        <li>Abnormal or missing nails</li>
        <li>In severe cases, internal organs may be affected</li>
      </ul>

      <h3><b>Types of EB</b></h3>
      <p><strong>The main types of EB are categorized based on where blisters form in the layers of the skin:</strong></p>
      <ul>
        <li>Epidermolysis Bullosa Simplex (EBS): Blisters occur in the outermost layer of skin (epidermis).</li>
        <li>Junctional Epidermolysis Bullosa (JEB): Blisters form in the junction between the epidermis and dermis (the deeper skin layer).</li>
        <li>Dystrophic Epidermolysis Bullosa (DEB): Blisters appear in the dermis due to issues with collagen.</li>
        <li>Kindler Syndrome: A less common form that involves multiple layers of the skin.</li>
      </ul>

      <h3><b>Causes</b></h3>
      <p>This disease is caused by mutations in genes that produce proteins important for the stability of skin and mucous membranes. Hereditary Epidermolysis Bullosa is inherited, typically in an autosomal dominant or recessive manner, depending on the type.</p>

      <h3><b>Prevention and Care</b></h3>
      <p>Since this is a genetic disorder, preventing its onset is difficult, but blisters can be reduced by avoiding skin friction and trauma. Close medical monitoring and skin care for patients are crucial to improving the quality of life.</p>
      <br/>
      <br/>
      <br/>
    </div>
  </div>
</div>
</section>

<!-- Articles Section -->
<section id="articles">
<div class="container">
  <br/>
  <br/>
  <br/>
  <div class="heading text-center">
    <h2>Articles</h2>
    <p>Read the latest articles on Hereditary Epidermolysis Bullosa and related topics</p>
  </div>
  <div class="row">
    <div class="col-md-4">
      <h4><a href="https://pubmed.ncbi.nlm.nih.gov/34916041/" class="special-link"><b>Pathophysiology and therapeutic challenges</b></a></h4>
      <p>EB is a group of inherited skin disorders caused by gene mutations affecting the skin's structural integrity, and recent advancements in understanding the disease mechanisms have led to the development of promising therapies like gene and cell therapy.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://researchoutput.ncku.edu.tw/en/publications/epidermolysis-bullosa " class="special-link"><b>Epidermolysis Bullosa (NCKU)</b></a></h4>
      <p>Epidermolysis bullosa (EB) is a rare inherited skin disorder characterized by blistering from minimal trauma, with over 30 subtypes classified by molecular abnormalities, and while there is no cure, advancements in gene and cell therapies offer hope for future treatments.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://pubmed.ncbi.nlm.nih.gov/36578049/" class="special-link"><b>Mutational analysis of epidermolysis bullosa in Taiwan by whole</b></a></h4>
      <p>A study of 77 Taiwanese patients with epidermolysis bullosa (EB) identified 60 mutations, including 22 novel ones, demonstrating that whole-exome sequencing is an effective first-line diagnostic tool for EB, with RNA sequencing useful for identifying splice-site mutations.</p>
    </div>
  </div>
  <div class="row">
    <div class="col-md-4">
      <h4><a href="https://pubmed.ncbi.nlm.nih.gov/34916041/" class="special-link"><b>New Hope for Treating the 4 Main Types of Epidermolysis Bullosa</b></a></h4>
      <p>Recent advancements in the understanding of epidermolysis bullosa have resulted in a fine-tuning of the classification of the disease group as well as the development of new possible therapies.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://www.ncbi.nlm.nih.gov/books/NBK599531/" class="special-link"><b>Epidermolysis Bullosa (NIH)</b></a></h4>
      <p>Epidermolysis bullosa (EB) defines a prototypic group of rare, inherited dermatoses, characteristically featuring skin fragility secondary to structural defects in the dermo-epidermal junction.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3750879/" class="special-link"><b>Inherited epidermolysis bullosa: clinical and therapeutic aspects</b></a></h4>
      <p>Inherited epidermolysis bullosa (EB) is a heterogeneous group of genetic disorders that present with skin and, in some cases, mucosal fragility, predisposing patients to the development of blisters</p>
    </div>
  </div>
  <div class="row">
    <div class="col-md-4">
      <h4><a href="https://pubmed.ncbi.nlm.nih.gov/37276163/" class="special-link"><b>Diacerein 1% Ointment for the Treatment of Epidermolysis Bullosa Simplex: A Randomized, Controlled Trial</b></a></h4>
      <p>In epidermolysis bullosa simplex (EBS), epithelial structural fragility results in blisters and erosions. Diacerein 1% ointment has been shown to reduce this blistering.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://www.mdpi.com/2227-9032/12/2/261" class="special-link"><b>Management of Skin Lesions in Patients with Epidermolysis Bullosa by Topical Treatment: Systematic Review and Meta-Analysis</b></a></h4>
      <p>Epidermolysis bullosa (EB) is the overarching term for a set of rare inherited skin fragility disorders that result from mutations in at least 20 different genes.</p>
    </div>
    <div class="col-md-4"></div>
      <h4><a href="https://www.sciencedirect.com/science/article/pii/S0190962218301300" class="special-link"><b>Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial</b></a></h4>
      <p>Epidermolysis bullosa simplex (EBS) is a rare genetic, blistering skin disease for which there is no cure. Treatments that address the pathophysiology of EBS are needed.</p>
    </div>
  </div>
  <br/>
  <br/>
  <br/>
</div>
</section>

<!-- Doctors Section -->
<section id="team" class="page-section">
  <div class="container">
    <br/>
    <br/>
    <br/>
    <div class="heading text-center"> 
      <!-- Heading -->
      <h2>Hospital and Specialists</h2>
    </div>
    <br/>
    <!-- Doctor's Details -->
    <div class="row feature design">
      <div class="area1 columns right">
        <h3>Chao-Kai Hsu</h3>
        <h4>Chairman, Genetic Center at National Cheng Kung University Hospital</h4>
        <h4>Associate Professor, Department of Dermatology,  College of Medicine, National Cheng Kung University</h4>
        <br/>
        <h4>Past Experiences:</h4> 
        <ul>
          <li>Training at St. John's Institute of Dermatology, King's College London (under Prof. John McGrath & Dr. Eduardo Calonje)</li>
          <li>Short-term training in Dermatology, Hokkaido University, Japan (under Prof. Hiroshi Shimizu)</li>
        </ul>
        <br/>
        <div class="row">
          <h4><a href="https://researchoutput.ncku.edu.tw/en/persons/chao-kai-hsu/publications/">Research Publications</a></h4>
          <h4><a href="https://web.hosp.ncku.edu.tw/nckm/">Hospital Information</a></h4></div>
        </div>
      <div class="area2 columns feature-media left"> <img src="images/Chao-Kai Hsu.jpg" alt="" width="100%"> </div>
    </div>
    
    <div class="row feature design">
      <div class="area1 columns right">
        <h3>Nessa Aghazadeh Mohandesi</h3>
        <h4>Dermatologist, Pediatric Dermatologist</h4>
        <h4>Children's Center Department, Pediatric and Adolescent Medicine Department, Dermatology Department, Clinical Genomics Department</h4>
        <br/>
        <h4>Past Experiences:</h4> 
        <ul>
          <li>Training at St. John's Institute of Dermatology, King's College London (under Prof. John McGrath & Dr. Eduardo Calonje)</li>
          <li>Short-term training in Dermatology, Hokkaido University, Japan (under Prof. Hiroshi Shimizu)</li>
        </ul>
        <br/>
        <div class="row">
          <h4><a href="https://www.mayoclinic.org/biographies/aghazadeh-mohandesi-nessa-m-d/bio-20550820">Research Publications</a></h4>
          <h4><a href="https://www.mayoclinic.org/patient-visitor-guide/minnesota/campus-buildings-maps/mayo-gonda-buildings?mc_id=us&utm_source=yext&utm_medium=l&utm_content=feature&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=102372&y_source=1_MzkxODQ2OC03MTUtbG9jYXRpb24ud2Vic2l0ZQ%3D%3D">Hospital Information</a></h4></div>
        </div>
      <div class="area2 columns feature-media left"> <img src="images/Nessa_Aghazadeh_Mohandesi.jpg" alt="" width="100%"> </div>
    </div>
    
    <div class="row feature design">
      <div class="area1 columns right">
        <h3>John W. Frew</h3>
        <h4>Dermatologist</h4>
        <h4>The Rockefeller University</h4>
        <br/>
        <h4>Past Experiences:</h4> 
        <ul>
          <li>Training at St. John's Institute of Dermatology, King's College London (under Prof. John McGrath & Dr. Eduardo Calonje)</li>
          <li>Short-term training in Dermatology, Hokkaido University, Japan (under Prof. Hiroshi Shimizu)</li>
        </ul>
        <br/>
        <div class="row">
          <h4><a href="https://www.medifind.com/doctors/john-w-frew/8407643">Research Publications</a></h4>
          <h4><a href="https://www.google.com/maps/place/1230+York+Ave,+New+York,+NY+10065%E7%BE%8E%E5%9C%8B/@40.7624486,-73.9560867,17z/data=!3m1!4b1!4m6!3m5!1s0x89c259ec9988a2f5:0xa452c574fb96e8b!8m2!3d40.7624486!4d-73.9560867!16s%2Fg%2F11y741rthc?entry=ttu&g_ep=EgoyMDI0MTEwNi4wIKXMDSoASAFQAw%3D%3D">Hospital Information</a></h4></div>
        </div>
      <div class="area2 columns feature-media left"> <img src="images/John W. Frew.jpg" alt="" width="160%"> </div>
    </div>
    <br/>
    <br/>
    <br/>
  </div>
  <!--/.container--> 
</section>

<!-- Function Section -->
<section id="groups">
<div class="container">
  <br/>
  <br/>
  <div class="heading text-center">
    <!-- Heading -->
    <h2>Patient Groups & Foundations</h2>
  </div>
  <div class="row">
    <div class="col-md-4">
      <h4><a href="https://www.eb-researchnetwork.org/about-us/network-partners/" class="special-link"><b>EB Research Network</b></a></h4>
      <p>The EB Research Network is a collaborative global network of organizations, researchers, and advocates working together to advance research and find treatments for Epidermolysis Bullosa.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://www.debra.org/" class="special-link"><b>Debra of America</b></a></h4>
      <p>Debra of America is a nonprofit organization dedicated to supporting people affected by Epidermolysis Bullosa (EB) through advocacy, research funding, and resources for individuals and families.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="http://www.eb.org.tw/ap/index.aspx " class="special-link"><b>Taiwan EB Association</b></a></h4>
      <p>The EB Association Taiwan is dedicated to improving the lives of individuals affected by Epidermolysis Bullosa (EB) in Taiwan through advocacy, support services, and raising awareness of this rare genetic condition.</p>
    </div>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    
    <a href="index.html" class="btn btn-primary">Back to Home</a>
  </div>
</div>
</section>

<footer>
<div class="container text-center">
  <p>&copy; 2024 RareInsight. All rights reserved.</p>
</div>
</footer>

<script src="js/jquery-1.8.
